Suchergebnisse - "Ma, Jingya"

PubPharm (29)

1

Intelligent interactive decision-making auxiliary system and method for patients with mild cognitive impairment

enthalten in: Europäisches Patentamt | 2023

von MA JINGYA | LI ZHENG | ZHAO LEI

2

Intelligent interactive decision-making auxiliary system and method for patients with mild cognitive impairment

enthalten in: Europäisches Patentamt | 2023

von MA JINGYA | LI ZHENG | ZHAO LEI

3

'Redeemed' or 'isolated' : A systematic review of the experiences of older adults receiving a mild cognitive impairment diagnosis

enthalten in: Geriatric nursing (New York, N.Y.) | 2023

von Ma, J. | Zhang, H. | Li, Z.

4

Understanding help-seeking decisions in people with subjective cognitive decline : A systematic review of qualitative studies

enthalten in: Geriatric nursing (New York, N.Y.) | 2021

von Zhang, H. | Zhou, Y. | Ma, J. | +1

5

Systematic review of physical exercise for patients with idiopathic inflammatory myopathies

enthalten in: Nursing & health sciences | 2021

von Zhang, H. | Liu, Y. | Ma, J. | +1

6

Systematic review of physical exercise for patients with idiopathic inflammatory myopathies

enthalten in: Nursing & Health Sciences | 2021

von Zhang, H. | Liu, Y. | Ma, J. | +1

7

Antibody-free detection of cellular neddylation dynamics of Cullin1

enthalten in: Analytical biochemistry | 2018

von Schwinn, M. | Hoang, T. | Yang, X. | +7

8

Improved Scheduling Mechanisms for Synchronous Information and Energy Transmission

enthalten in: Sensors (Basel, Switzerland) | 2017

von Qin, D. | Yang, S. | Zhang, Y. | +2

9

Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi

enthalten in: Toxicology research | 2016

von Csizmadia, V. | Hales, P. | Tsu, C. | +8

10

Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi

enthalten in: Toxicology research | 2016

von Csizmadia, V. | Hales, P. | Tsu, C. | +8